Benzinga · Nov 13, 2026
Wells Fargo Maintains Equal-Weight on Cigna Group, Raises Price Target to $325
Wells Fargo analyst Stephen Baxter maintains Cigna Group (NYSE:CI) with a Equal-Weight and raises the price target from $307 to $325.

NASDAQ · CI
Healthcare · Medical - Healthcare Plans
$273.04
Down-$12.33 (-4.32%)
Updated Nov 20, 2026, 2:20 AM
SID Score
7.1/10
Composite research score
Smart Money
58/100
Neutral
Price performance · CI
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 19, 2026
CI closed at $273.04 after 21 trading sessions, down 13.56% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 19, 2026 | $284.22 | $285.08 | $267.22 | $273.04 | 3.65M |
| Nov 18, 2026 | $292.50 | $294.06 | $283.02 | $285.37 | 2.49M |
| Nov 17, 2026 | $297.16 | $298.45 | $292.69 | $294.06 | 1.53M |
| Nov 16, 2026 | $301.80 | $303.65 | $298.115 | $300.16 | 1.33M |
| Nov 13, 2026 | $298.80 | $298.80 | $292.28 | $297.00 | 1.44M |
| Nov 12, 2026 | $303.56 | $304.125 | $294.90 | $296.27 | 1.62M |
| Nov 11, 2026 | $300.73 | $302.22 | $293.21 | $301.45 | 1.47M |
| Nov 10, 2026 | $297.00 | $303.185 | $295.65 | $303.13 | 1.49M |
| Nov 9, 2026 | $295.00 | $298.05 | $291.57 | $295.60 | 1.88M |
| Nov 6, 2026 | $293.47 | $297.30 | $292.35 | $293.59 | 2.43M |
| Nov 5, 2026 | $318.00 | $318.05 | $299.665 | $301.48 | 2.77M |
| Nov 4, 2026 | $301.96 | $307.11 | $296.50 | $305.41 | 2.43M |
| Nov 3, 2026 | $293.72 | $297.68 | $293.21 | $295.44 | 1.86M |
| Nov 2, 2026 | $300.47 | $300.50 | $291.93 | $295.19 | 1.51M |
| Oct 30, 2026 | $302.79 | $303.425 | $297.38 | $298.23 | 1.86M |
| Oct 29, 2026 | $300.84 | $300.90 | $295.44 | $298.41 | 1.27M |
| Oct 28, 2026 | $296.04 | $299.54 | $294.115 | $295.00 | 1.02M |
| Oct 27, 2026 | $304.68 | $306.74 | $297.00 | $298.28 | 1.36M |
| Oct 26, 2026 | $307.09 | $310.95 | $304.45 | $305.78 | 1.79M |
| Oct 23, 2026 | $314.75 | $315.86 | $305.51 | $306.95 | 1.78M |
| Oct 22, 2026 | $305.73 | $316.265 | $304.675 | $315.88 | 1.58M |
The latest Smart Investors Daily articles mentioning CI.
Company
Market Activity
Research & News
CI research
Company profile and research snapshot.
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense (current contract through 2029), and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of December 2024.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Nov 13, 2026 | Wells Fargo | Equal-Weight | — |
| Nov 12, 2026 | Piper Sandler | Overweight | — |
| Nov 12, 2026 | Jefferies | Hold | — |
| Nov 11, 2026 | Bernstein | Outperform | — |
| Nov 9, 2026 | Barclays | Equal-Weight | — |
No generated briefing is available yet.
Benzinga · Nov 13, 2026
Wells Fargo analyst Stephen Baxter maintains Cigna Group (NYSE:CI) with a Equal-Weight and raises the price target from $307 to $325.
Yahoo · Nov 13, 2026
Cigna Group’s shares may be trailing its industry peers and the broader market, but it hasn’t slipped into the red. Analysts still see enough long-term potential to stay moderately bullish.
Yahoo · Nov 13, 2026
Cigna Group reported third quarter 2026 revenue of US$73,683 million and net income of US$1,442 million, and projected 10% to 14% annual adjusted EPS growth through 2030 supported by a US$3 billion modernization and productivity program. The Specialty and Care Services unit generated stronger pre tax adjusted income through wider use of lower cost biosimilars and specialty generics, which now sits alongside long term earnings guidance as a key pillar of Cigna Group’s business story. This...
Yahoo · Nov 12, 2026
Our new list of the 10 Best Stocks to Buy After Democrats’ Election Sweep, According to CIBC is live, and Cigna Group (NYSE:CI) ranks 9th on it. CIBC Capital Markets recommended a list of top stock picks after the Democratic sweep of Congress, according to CNBC, citing a potentially tougher regulatory environment for corporate America. […]
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning CI.